Global Burn and Scald Medicine Market Growth 2025-2031

The global Burn and Scald Medicine market size is predicted to grow from US$ 472 million in 2025 to US$ 593 million in 2031; it is expected to grow at a CAGR of 3.9% from 2025 to 2031.

Burns are a common traumatic disease caused by physical or chemical factors, such as heat, chemistry, electric current and radiation. Small-area burns only cause damage to the skin and (or) mucosal tissue or the corresponding deep tissue. However, larger-area burns can cause functional, metabolic and morphological changes in various systems of the body to varying degrees, causing severe systemic reactions and visceral damage in the injured, and complications such as shock, sepsis and multiple organ failure, with a high mortality rate. The healing and treatment process of burn wounds is complex and takes a long time. After the wound heals, sequelae such as scar contracture and functional impairment may remain. Therefore, burns, especially large-area burns, are the most complex and serious traumatic diseases. In order to treat patients with large-area severe burns, in addition to the need for specialists to have solid basic medical knowledge and experience in burns, other departments such as general surgery, cardiothoracic surgery, urology, orthopedics, anesthesiology and internal medicine need to work together for consultation and treatment to form a team to achieve success. This is the result of collective efforts, cooperation and collaborative work. Burn and scald medicines refer to medicines used to treat skin or tissue damage caused by heat (such as flames, hot water, steam), chemicals, electric current or radiation. The main functions of these medicines are to relieve pain, prevent infection, promote wound healing and reduce scar formation. According to the severity and type of burns, burn and scald medicines can be divided into topical medicines, oral medicines and new therapies. The statistical object of this article is topical medicines for burns and scalds.

The global market for burn and scald medicine is showing a steady growth trend, mainly driven by the improvement of medical standards, the increase in the incidence of burn accidents and the increase in people's health awareness. With the development of industrialization, the acceleration of urbanization and the increase in accidental injuries in the home, the demand for burn and scald treatment drugs is gradually increasing. New drugs are constantly emerging in the field of modern medicine, including growth factor drugs, bioengineered skin substitutes and silver-containing antibacterial drugs. These innovative therapies effectively improve the healing speed of wounds and reduce the risk of infection. At the same time, Chinese herbal medicine and natural plant extracts are gradually gaining market attention as auxiliary treatments, especially in Asia. The North American and European markets are dominated by advanced medical technology and high medical expenditures, while the Asia-Pacific region has become the fastest growing region due to its large population base, increased medical investment and increased public health awareness. The challenges facing the market include high drug research and development costs, complex approval processes, drug side effects and drug resistance. Major players focus on R&D innovation, expanding indications, and improving competitiveness through mergers and acquisitions and strategic cooperation. In the future, with the development of precision medicine and the promotion of personalized treatment plans, the market for burn and scald drugs is expected to maintain steady growth, especially drugs with significant wound healing effects and low side effects, which have greater market potential.

LP Information, Inc. (LPI) ' newest research report, the “Burn and Scald Medicine Industry Forecast” looks at past sales and reviews total world Burn and Scald Medicine sales in 2024, providing a comprehensive analysis by region and market sector of projected Burn and Scald Medicine sales for 2025 through 2031. With Burn and Scald Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Burn and Scald Medicine industry.

This Insight Report provides a comprehensive analysis of the global Burn and Scald Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Burn and Scald Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Burn and Scald Medicine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Burn and Scald Medicine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Burn and Scald Medicine.

This report presents a comprehensive overview, market shares, and growth opportunities of Burn and Scald Medicine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Ointment
Spray
Oil
Other

Segmentation by Application:
Hospitals and Clinics
Retail Pharmacies
E-commerce Platforms
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Mebao Pharmaceutical Technology Group
B. Braun
Integra LifeSciences
Jinyao Darentang
Smith & Nephew
Yangtze River Pharmaceutical Group
STADA Thornton & Ross
Kenvue Brands LLC
Changchun Overseas Pharmaceutical Group Co., Ltd.
Orkla Health
Guangdong Hengjian Pharmaceutical
Otsuka Pharmaceutical Co., Ltd.
Tonghua Maoxiang Pharmaceutical Co., Ltd.
Cipla
Tanabe Mitsubishi Pharmaceuticals
Chongqing Xixuan Biotechnology Co., Ltd.
Quest Products, LLC
Jianmin Group Yekai Thai Pharmaceutical (Suizhou)
Acme United Corp.
Dongwha Pharm
China Resources Pharmaceutical Group
Safetec Of America
Taiji Group Sichuan Mianyang Pharmaceutical Co., Ltd.
North China Pharmaceutical Hebei Huanuo
Xiangxi Hongcheng Pharmaceutical
Hebei Aoxing Group Pharmaceuticals
Jilin Aodong Pharmaceutical Group
Beijing Tongrentang
Henan Quanyu Pharmaceuticals
Chengdu First Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Burn and Scald Medicine market?

What factors are driving Burn and Scald Medicine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Burn and Scald Medicine market opportunities vary by end market size?

How does Burn and Scald Medicine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.